Related Articles
P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences
TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples
Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment
Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review
Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors.